Arrayit Corporation (ARYC)

[Play4keeps2]

There are a lot of people throwing terms around, like "scam", for Arrayit. Every time penny stocks go down, the litany begins. I am concerned, as expressed on this board, why fins haven't posted yet, and why we seem to be dangled along. Obviously, there is (are) some good reason(s), because I know Arrayit managers want them posted, too.

I have had to conclude IMO, that whether or not there is a big PR day after tomorrow, and whether or not fins are posted by "Fall 2018," this company is going to great places soon. Forget tweets, although they give us great info on the company progress, and must be valid since the SEC allows formal corporate communications through tweeting. Although there are many other factors that give me confidence in Arrayit, all I have to do is read the last PR on Dec 3rd, and I have great confidence ARYC pps will move much higher in the near future.

Some try to capitalize on fear: fear of delisting, fear of a scam, fear of "losing it all," etc. Don't let fear win out. Make your decisions based on what's best for you. This is risky, but also has potential for incredible reward. It's your choice to invest or not. Only you should make that choice. All IMO. Part of the Dec 3rd PR is reposted below. GLTA.

Sunnyvale, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces a new allergy testing services agreement with a major healthcare company specializing in patient health and wellness. Arrayit offers simple non-invasive testing services that measure reactivity of immunoglobulin E (IgE) antibodies to an extensive panel of food, environmental and specialty allergens as a precision healthcare solution to assist physicians in the diagnosis and treatment of allergy and asthma. The healthcare leader provides health and pharmacy services to more than 10 million retail, commercial and corporate customers and reports revenues exceeding $35,000,000,000 ($35 billion dollars) annually.

Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, signed allergy testing contracts with a consortium of 178 medical clinics, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing by the Centers for Medicare and Medicaid Services (CMS), reported the sale and shipping of clinical instrumentation to the FDA, launched the Patient Data Solutions allergy portal for doctors and clinics, and celebrated 25 years of company operations. Adding a major new payor in the health and wellness sector expands Arrayit’s allergy testing footprint among healthcare recipients in both the government and commercial health insurance markets.